stilnox tablet 10 mg
sanofi-aventis singapore pte. ltd. - zolpidem tartrate - tablet, film coated - 10 mg - zolpidem tartrate 10 mg
cordarone injection 150 mg3 ml
sanofi-aventis singapore pte. ltd. - amiodarone hcl - injection - 150 mg/3 ml - amiodarone hcl 150 mg/3 ml
coplavix tablets film-coated
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - tablets film-coated - 75mg+ 100mg
solian
sanofi winthrop industrie - amisulpride - tablets scored - 100mg
solian
sanofi winthrop industrie - amisulpride - tablets scored - 200mg
praluent solution for injection pre-filled syringe 150 mgml
sanofi-aventis singapore pte. ltd. - alirocumab - injection, solution - alirocumab 150mg
praluent solution for injection pre-filled syringe 75mgml
sanofi-aventis singapore pte. ltd. - alirocumab - injection, solution - alirocumab 75mg
plavix 75 mg
sanofi israel ltd - clopidogrel as hydrogen sulfate - film coated tablets - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - secondary prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.
orelox 100mg tablets
sanofi winthrop industrie, france - cefpodoxime - tablet - 100 mg
kevzara 200mg sol. for inj. in pre - filled pen solution for injection
sanofi winthrop industrie, france - sarilumab - solution for injection - 200 mg